In vitro antitumor effect of metformin in murine 4T1 breast cancer cell line
محل انتشار: دوازدهمین کنگره بین المللی سرطان پستان
سال انتشار: 1394
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 492
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED12_212
تاریخ نمایه سازی: 2 تیر 1397
چکیده مقاله:
Introduction: Breast cancer is the most commonly diagnosed cancer in women. Previous studies have showed that the anti-diabetic drug metformin as potential anti-tumor agent that could targeting breast cancer cell. Thus this study was designed to evaluate the anti-tumoral effect of metformin on 4T1 breast cancer cell line. Methods: 4T1 cells were cultured in RPMI supplemented 10% FBS and incubated in 5% co2 at 37°C. Then the effect of metformin in the different concentrations (0-10-20-40-60-80-100 m mol/l) was tested by MTT assay and the cell viability was measured after 5 day incubation. Results: The result of MTT assay showed that the IC50 value (i.e., the concentration of metformin required to decrease MTT metabolization by 50%) ranged from 60±2 m mol/l metformin in 4T1 breast canc er cell Conclusion: These results demonstrated that metformin could be used an effective antitumor drug, and has the potential to developed as a new anticancer drug
کلیدواژه ها:
نویسندگان
Elham yousefi
MSc student of immunology, Department of Microbiology, Faculty of veterinary Medicine, urmia university, Urmia,Iran
Nowroz delirezh
Associate professor, Department of Microbiology, Faculty of veterinary Medicine, urmia university, Urmia, Iran.